Aminopeptidase B (Ap-B) is a Zn 2þ-aminopeptidase of the M1 family which is implicated, in conjunction with the nardilysin endoprotease, in the generation of miniglucagon, a peptide involved in the maintenance of glucose homeostasis. Other in vivo physiological roles have been established for this vertebrate enzyme, such as the processing of Arg-extended forms of human insulin and cholecystokinin 9 and the degradation of viral epitopes in the cytoplasm. Among M1 family members, Ap-B is phylogenetically close to leukotriene A 4 hydrolase (LTA 4 H), a bi-functional aminopeptidase also able to transform LTA 4 in LTB 4 (a lipid mediator of inflammation). As the activities of LTA 4 H are reported to be inhibited by resveratrol, a polyphenolic molecule from red wine, the effect of this molecule was investigated on the Ap-B activity. Several other active phenolic compounds produced in plants were also tested. Among them, curcumin and mangiferin are the most effective inhibitors. Dixon analysis indicates that curcumin is a non-competitive inhibitor with a Ki value of 46 mmol.L À1. Dixon and Lineweaver-Burk representations with mangiferin show a mixed non-competitive inhibition with Ki' and Ki values of 194 mmol.L À1 and 105 mmol.L À1 , respectively. At 200 mmol.L À1 , no significant effect was observed with caffeic, chlorogenic, ferulic, salicylic and sinapic acids as well as with resveratrol. Analyses on the 3D-structure of LTA 4 H with resveratrol (pdb: 3FTS) and the Ap-B 3D-model allow hypothesis to explain theses results.